Aspire Capital Fund LLC 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-12-23 4:42 pm Purchase | 2020-12-23 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Aspire Capital Fund LLC | 18,000 5.050% | 18,000 (New Position) | Filing |